The Department of Defense reportedly expects to increase its use of unmanned aerial systems (“drones”) by nearly 50% in the next few years. At the same time, however, the rate of DoD’s procurement of drones is projected to decline sharply from FY2016-2020.
The Congressional Research Service takes note of the seeming contradiction and proposes several possible explanations to resolve it. See How Many UAVs for DoD?, CRS Insights, August 27, 2015.
Other new and updated CRS publications that became public last week include the following.
Policy Implications of the Internet of Things, CRS Insights, August 25, 2015
Health Insurance: Small is the New Large, CRS Insights, August 26, 2015
Gold King Mine Spill May Renew Interest in “Good Samaritan” Legislation, CRS Insights, August 27, 2015
Financial Regulatory Improvement Act Included in Senate Appropriations Bill, CRS Insights, August 27, 2015
Terrorism Victims Sue to Enjoin Sanctions Relief under the Iran Nuclear Agreement, CRS Legal Sidebar, August 27, 2015
District of Columbia: A Brief Review of Provisions in District of Columbia Appropriations Acts Restricting the Funding of Abortion Services, updated August 27, 2015
Drug Testing and Crime-Related Restrictions in TANF, SNAP, and Housing Assistance, updated August 28, 2015
The Patient Protection and Affordable Care Act’s Essential Health Benefits (EHB), August 27, 2015
Navy Ship Names: Background For Congress, updated August 26, 2015
The transition to a clean energy future and diversified sources of energy requires a fundamental shift in how we produce and consume energy across all sectors of the U.S. economy.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.